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ABSTRACT 
 
Sex Differences in Collateral Remodeling Following Hindlimb Arterial Occlusion 
 
Laura Lenae Burckhardt 
 
 
 
Clinical evidence indicates a higher incidence of peripheral arterial occlusive disease and 
associated likelihood of critical limb ischemia in women, as well as worse prognosis and 
decreased survival post myocardial infarction. Therefore, understanding the possible 
differences in underlying vascular compensation mechanisms is crucial. With arterial 
occlusions, necrosis and tissue injury can be naturally mitigated by the collateral 
circulation, improving patient prognosis. Previous sex-comparison studies describing 
differences in vascular remodeling are inconsistent. Therefore, the aim of this study was 
to describe the effect of arterial occlusion on collateral remodeling in healthy male and 
healthy reproductive-stage female mice. At 7 days following femoral artery ligation in 
C57Bl/6 and BALB/c mice, there were no sex-related differences in functional 
ambulatory recovery. There were no sex-related differences in mechanoadaptation 
indicators in the collateral stem- vascular smooth muscle cell (VSMC) length and 
overlap, with the exception of longer smooth muscle cells in male C57Bl/6 mice, VSMC 
lengths 329 ± 19  verses 288 ± 13 µm, male and female. Collateral midzone luminal and 
abluminal diameters, as well as wall thicknesses were not different between sexes. As 
comprehensive sex-specific differences were not captured in our specific investigation of 
arteriogenesis, an evaluation of microvascular remodeling in the ischemic zone and 
collateral vasodilation would be of interest, as would evaluating arteriogenesis following 
oophorectomy with estrogen depletion. The determination of any underlying mechanistic 
sex-specific differences could be the foundation for which targeted therapeutics are 
developed, which will be crucial for closing the prognosis gap between men and women 
in the global treatment of peripheral arterial occlusive disease.   
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INTRODUCTION 
Peripheral arterial occlusive disease (PAOD), an atherosclerotic narrowing of the arteries 
distal to the aortic bifurcation, affects an estimated 10 percent of the global population, 
including 27 million patients in the United States and Europe [4-7]. Critical limb 
ischemia (CLI), the most severe manifestation of PAOD, has 500 to 1000 new cases 
diagnosed yearly per million of the population, with an estimated annual cost of 40-66 
billion dollars [8]. CLI can lead to amputation or death without proper treatment, with 
four-year survival rates as low as 40 percent [9]. Recent clinical evidence suggests a 
higher incidence of PAOD in females, and an associated higher likelihood of critical limb 
ischemia [10-15]. Women are also less likely to survive, and exhibit worse prognosis 
following a myocardial infarction (MI) [16, 17]. Within women, ovariectomy before age 
35 increases the risk of a nonfatal MI by 7.2 times that of premenopausal women [18]. In 
patients with severe coronary artery lesions, the male sex was associated with increased 
collateralization [19], therefore, these differences in outcomes could be due to underlying 
molecular and cellular sex-related differences in vascular compensation methods [20, 21].      
 
With arterial occlusions, necrosis and tissue injury can be naturally mitigated by the 
collateral circulation, improving patient prognosis [22-24]. When a hemodynamically-
relevant stenosis occurs in a main feeding artery, blood is redirected to downstream 
tissues through the collateral vessel(s), which connects the high-pressure region upstream 
of the stenosis to the low-pressure region downstream. The increased blood velocity and 
shear stress through the collaterals initiates outward remodeling through arteriogenesis, 
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allowing the collateral to improve patient prognosis by maintaining tissue perfusion [3, 
25].  
 
During this outward remodeling, vessel caliber increases in a process involving monocyte 
extravasation and transformation into cytokine-, growth factor-, and enzyme-secreting 
macrophages. Specific secreted agents, such as vascular endothelial growth factor A 
(VEGF-A) and fibroblast growth factor 2 (FGF-2), promote proliferation of endothelial 
and vascular smooth muscle 
cells (VSMCs) in classical 
arteriogenesis, Figure 1 [26-
32]. Although outward 
remodeling usually involves 
VSMC proliferation, inward 
remodeling can involve both 
VSMC apoptosis [33-37] 
and changes in VSMC 
length, increasing cellular 
overlap through a process 
described as 
mechanoadaptation [38]. As 
inward remodeling involves 
a continuum from changes in 
apoptosis to VSMC 
 
FIGURE 1 | Arteriogenesis.  (A) Classical mechanism of 
arteriogenesis [1]. (B) Outward collateral remodeling, from 
normal blood flow (left) to altered flow due to arterial 
occlusion (right) [3].   
A 
B 
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morphology, outward remodeling may also involve a continuum from proliferation to 
changes in VSMC morphology.  
 
In addition to VSMC proliferation, 
outward remodeling also requires a 
transient inflammatory response, 
moderate oxidative stress, and 
activation of the nitric oxide (NO) 
pathway, Figure 2, with all three 
processes partially modulated by 
estrogens [39-42]. Estradiol levels 
in men and postmenopausal women 
are lower than levels in non-
pregnant women, possibly explaining the differences in outward remodeling [43-45]. 17-
β-estradiol increases the endothelial production of nitric oxide and flow-mediated 
outward remodeling following oophorectomy is rescued by 17-β-estradiol [42, 46]. 
Oophorectomy also increases blood pressure and decreases vessel densities in rabbits, 
indicators of angiogenesis and arteriogenesis [47].  
 
However, sex comparison of arteriogenesis without female estrogen depletion is of value 
due to female hormonal cycle variation in the general population, as well as the presence 
of PAOD in females prior to the average age of natural menopause [11, 43, 48, 49]. 
Following femoral excision, similar blood pressure and vessel densities were observed in 
 
FIGURE 2 | Nitric oxide vasodilation mechanism [1, 2].  
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male and non-oophorectomized female rabbits, although collateral number was not 
examined [47]. Furthermore, female mice without oophorectomy exhibit higher hindlimb 
vascular resistance, less responsiveness to vasodilators, and more sensitivity to 
vasoconstrictors following arterial occlusion [50].  
 
The inconsistency in female flow-recovery impairment following femoral artery 
occlusion or excision within a small body of literature necessitates further study [21, 47, 
50]. Increased vascular resistance in female mice is suggestive of impaired collateral 
enlargement, therefore we evaluated the extent and mechanisms of collateral enlargement 
throughout the gracilis collateral circuit in male and female mice. The aim of this study 
was test the hypothesis that healthy male mice exhibit superior collateral remodeling to 
healthy reproductive-stage female mice following femoral artery ligation. This was 
performed by evaluating daily hindlimb use, mechanoadaptation in the gracilis collateral 
stem, and collateral enlargement in the gracilis collateral midzone. 
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MATERIALS AND METHODS  
Animals  
All experimental procedures were performed according to the protocols approved by the 
Institutional Animal Care and Use Committee (IACUC) of California Polytechnic State 
University. Female and male eight-week old C57Bl/6 and BALB/c mice were obtained 
from Taconic Farms, Jackson Laboratories, or Charles River Laboratories. Eight female 
and eight male C57Bl/6, and six female and six male BALB/c mice were used for the 
mechanoadaptation and collateral remodeling studies. All mice were maintained on a 
12:12 hour light:dark cycle in a temperature controlled room in the University Vivarium. 
Mice were housed by sex with littermates in micro-isolator cages, supplied with feed, 
water, and enrichment (‘houses’, nesting material, and tubes), and inspected daily.  
 
Collateral Enlargement Model 
Collateral enlargement was induced in the superficial gracilis collaterals by ligating the 
femoral artery between the profunda femoris and popliteal branches of the left hindlimb, 
as described previously [51]. Briefly, mice were anesthetized using 1-3% isoflourane gas 
at an oxygen flow rate of 0.8-1.2 l⋅min-1, administered through a ‘nose-cone’, and given 
pre-operative analgesic (buprenorphine, 0.075 mg·kg-1 subcutaneous). Hair on the medial 
hindlimb was depilated and the surgical area was disinfected with chlorohexidine 
diacetate. Mice were placed supine on a heated surgical stage, adjusted to maintain a core 
body temperature of 35°C. Ophthalmic ointment was applied to the eyes to avoid corneal 
desiccation. 
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A small skin incision (1-2 cm) was made on the middle, medial aspect of the left thigh, 
with subcutaneous connective tissue blunt dissected to maximize surgical exposure. 
Throughout the procedure, the incision site was irrigated with sterile phosphate buffered 
saline (PBS) to prevent tissue desiccation. To expose the ligation site, the epigastric fat 
pad was reflected medially, and the femoral artery was blunt dissected from the 
neurovascular bundle before ligation with 6.0 silk suture distal to the epigastric branch 
and proximal to the popliteal branch [51]. The skin was closed using 7.0 polypropylene 
suture. For control, the surgical procedure outlined above was performed on the 
contralateral hindlimb, with the exception of ligating the femoral artery. Animals were 
given post-operative buprenorphine (0.075 mg·kg-1), and supplied with buprenorphine 
water (0.01 mg·ml-1) for approximately 2-3 days.  
 
Clinical Ambulation Scoring  
Following surgery, animals were observed daily for ambulation, and scored from 0-3 
based on hindpaw range of motion, as described previously [52]. A dragging hindpaw 
was scored as a 3, no plantar flexion and constant dorsiflexion a 2, some plantar flexion a 
1, and normal use a 0. Animals were monitored until normal ambulation was observed on 
two consecutive days, or until day-7 post ligation. 
 
Perfusion Fixation and Microfil Infusion 
In preparation for vascular casting and immunofluorescence, mice were perfusion fixed 
with paraformaldehyde. Through a thoracotomy, an incision was made in the apex of the 
heart into the left ventricle, and a catheter was inserted and secured with a vascular 
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clamp, Figure 3A. A cycle of 40 ml vasodilator cocktail heated to 37 °C (5 U·µL-1  
heparin, 10-3 M sodium nitroprusside, 10-4 M adenosine, in PBS), followed by 5 ml 4% 
paraformaldehyde (PFA), was injected through the catheter with a syringe pump (5 
ml·min-1), Figure 3B. Following fixation, microfil agents were combined, and 1 ml was 
injected (0.5 ml·min-1). Once the Microfil perfused distal to the knee, both ankles were 
ligated with silk suture to prevent entry into venous circulation through ankle A-V shunts, 
Figure 3C. Microfil infusion continued until the casting agent reached the anterior 
gracilis collateral (approximately 3 ml of additional solution). Post infusion, the exposed 
tissue was covered with plastic wrap and Microfil polymer cured overnight at room 
temperature. The anterior gracilis muscle and profunda femoris artery were resected and 
post fixed in 4% PFA for approximately 24 hours before rinsing and storing in PBS at 4 
°C.  
 
FIGURE 3 | Perfusion fixation and Microfil injection methods. (A) Thoracotomy with 
catheter insertion. (B) Setup with syringe pump. (C) Murine ankles ligated during Microfil 
injection. 
 
A      B                                       C         
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Immunofluorescence  
Immunofluorescence was used to determine collateral vessel diameters and smooth 
muscle cell mechanoadaptation. Whole gracilis anterior muscles were stained with α-
smooth muscle actin (Sigma Aldrich Anti-Actin α-Smooth Muscle Cy3™ Antibody, 
C6198) in a solution with 0.1% saponin and 2% BSA in PBS for 3 days at 4°C. After 
staining, muscles were washed in 0.1% saponin in PBS 3x for 20 minutes at room 
temperature, and PBS for 30 minutes. The samples were mounted onto depression slides 
with 50:50 PBS:glycerol to clear. 
 
The midzone of the anterior gracilis collateral was captured with widefield fluorescence 
microscopy (α-smooth muscle actin) and widefield microscopy (Microfil cast). All 
anterior gracilis collateral inner and outer diameters were measured at the collateral 
midzone in three locations using ImageJ.  
 
Confocal microscopy was used to visualize smooth muscle cells around each artery to 
assess smooth muscle cell overlap and length (mechanoadaptation indicators). Utilizing a 
40x oil immersion objective, images of the collateral stem region of the profunda femoris 
artery were captured with Fluoview Viewer software (Olympus, FV10-ASW 4.1). Image 
stacks in the z-direction were captured with 1-micron slices for approximately half the 
diameter for each artery. To assess mechanoadaptation in the collateral stem, the z-stacks 
of the profunda femoris were merged into single, 3-D reconstructions, and smooth muscle 
cell overlap between the individual cells and smooth muscle cell length were measured 
using ImageJ software, as described previously [38, 53]. Briefly, a 100µm length of 
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artery was delineated from each 3D reconstruction, and average VSMC length for each 
vessel, Lv, was determined using Equation 1 below [38, 53]:’ 𝐿# = 4𝜋𝑅#𝐹(𝑆+ + 𝑆-)/𝑇#                                               (Eq. 1) 
In equation 1, Lv is the average VSMC length, Rv the radius of the artery, F the fraction 
of vessel circumference in which measurements were made, Sw the number of wrap cells, 
St the length of all tapered cells divided by the length of one wrap cell, and Tv the number 
of taper cells.  
 
Statistical Analysis   
Differences in daily ambulation scores were determined using a repeated measures 
analysis of variance (ANOVA). Differences in intersex or interstrain ambulation scores, 
collateral stem VSMC lengths and overlaps, collateral midzone inner and outer 
diameters, and collateral midzone wall thicknesses were determined using independent t-
tests. All values are expressed as mean ± standard error of the mean. 
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RESULTS 
Functional Impairment Following Femoral Artery Ligation 
Previous investigations of male-female differences in response to arterial occlusion 
suggested that deficits observed in female mice were likely attributable to reduced 
collateral remodeling or fewer collateral number [50]. However, because recovery from 
femoral artery resection involves both collateral enlargement in the thigh along with 
angiogenesis and capillary arterialization in the leg [54, 55], we sought to evaluate the 
impact of female sex in an arterial occlusion model that involves primarily collateral 
enlargement [56]. Surprisingly, there was no difference in hindlimb use between male 
and female C57Bl/6, which was normalized by 3.9 ± 0.4 days for both, Figure 4. If 
anything, C57Bl/6 female mice may have recovered normal hindlimb use before the 
males, but this was only statistically different at the day-5 time point. Female C57Bl/6 
mice were statistically different at days 1, 2, and 5 from the rest of the days scored for 
that group, and male C57Bl/6 were different at days 1 and 6. Female BALB/c mice were 
different at days 4 and 6 from the rest of the days scored for that group, and male 
BALB/c mice were different at days 4, 5, and 6. As expected, BALB/c mice regained 
normal hindlimb function more slowly, but there was no difference between males and 
females, 5.8	± 0.2 and 6.0 ± 0 days, respectively. As ambulation was only scored up to 6 
days, these data suggest that BALB/c mice hindlimb function did not return to normal use 
during the experiment.  
 
Although no difference in hindlimb use suggests a similar degree of collateral 
enlargement between male and female mice, hindlimb use is a sufficiently coarse 
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assessment that depends upon more than collateral flow. Therefore, we specifically 
evaluated collateral remodeling between male and female mice following femoral artery 
ligation.  
 
A 
 
FIGURE 4 | Hindlimb ambulation scoring following femoral artery ligation in BALB/c 
and C57Bl/6 mice. (A) Days to normal ambulation in BALB/c female (n=6) and male mice 
(n=6), and C57Bl/6 male (n=13) and female (n=13) mice. The infinity sign (∞) indicates mice 
did not return to normal hindlimb function during experiment. (B) Daily ambulation scores for 
BALB/c female (n=6) and male (n=6) mice, and C57Bl/6 female (n=13) and male (n=13) 
mice. *P<0.05 male verses female intrastrain. 
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Mechanoadaptation in the Collateral Stem 
Although the collateral stem enlarges following femoral artery ligation, the absence of 
smooth muscle cell proliferation suggests the enlargement is not due to typical 
arteriogenesis [57, 58]. To test the hypothesis that enlargement in the collateral stem 
occurs via mechanoadaptation, change in vascular diameter by the modification of 
VSMC length and overlap, and to determine if female mice are deficient in this process, 
we assessed smooth muscle cell length and overlap utilizing confocal microscopy at day 
7 in both sham-operated and ligated profunda femoris arteries in male and female 
C57Bl/6 mice. Although the native anatomy of smooth muscle cells in the collateral stem 
of C57Bl/6 male and female mice was not different, VSMCs were longer in males 
following remodeling, and VSMC lengths in both sexes were greater than the 
contralateral controls, Figure 5C. Consistent with mechanoadaptation, smooth muscle 
cell overlap decreased at day-7 post ligation in both sexes, but there was no difference 
between male and female mice Figure 5D.  
As BALB/c mice have lower collateral density and decreased collateral remodeling when 
compared to C57Bl/6 mice at day-21 following ligation, we examined enlargement in this 
model [52, 56]. There was no difference in VSMC lengths of male and female collateral 
stems in BALB/c mice, and remodeling was consistent, with all VSMC lengths greater in 
both male and female mice following ligation than the contralateral controls. 
Smooth muscle cell overlap decreased at day-7 post ligation in both male and female 
BALB/c mice, consistent with mechanoadaptation, Figure 5D. Despite the native 
anatomy of the BALB/c mice differing with VSMC overlap shorter in male than female 
mice in the non-ligated group, there was no difference in remodeled collateral stem 
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VSMC overlaps between male and female BALB/c mice. 
 
 
  A 
B 
C 
FIGURE 5 | Indicators of mechanoadaptation in BALB/c and C57Bl/6 Mice. (A) 
Representative image of profunda femoris artery under confocal microscopy (40x). (B) 
Representative image of smooth muscle cell overlap (yellow) and length (green). (C) 
Smooth muscle cell lengths in the profunda femoris artery of day-7 post-ligation and 
control hindlimbs in BALB/c female (n=4,5) and male (n=4,5) mice, and C57Bl/6 
female (n=8,7) and male mice (n=6,7). (D) Smooth muscle cell overlap in the 
profunda femoris artery of day-7 post-ligation and control hindlimbs in BALB/c 
female (n=4,5) and male (n=4,5) mice, and C57Bl/6 female (n=8,7) and male (n=6,7) 
mice. *P<0.05 verses control conditions. **P<0.05 for male versus female C57. 
D 
B 
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Anterior Gracilis Collateral Remodeling Post-Femoral Artery Ligation  
Having compared the mechanoadaptation events between males and females, we next 
evaluated the arteriogenesis response in the collateral midzone within the anterior gracilis 
muscle [56]. To determine if female mice exhibit impaired arteriogenesis, we measured 
outward remodeling (based on luminal diameter) and measured abluminal diameter so 
that we could calculate wall thicknesses and identify any differences in the type of 
remodeling that occurred (i.e. hypertrophic, eutrophic, or hypotrophic), Figure 6, in male 
and female C57Bl/6 and BALB/c mice. As expected, robust outward remodeling 
occurred, as the luminal diameter was larger for all ligated gracilis collaterals compared 
to the respective contralateral control, for both male and female C57Bl/6 mice, Figure 
6E. The abluminal diameter was also larger for both male and female C57Bl/6 mice, and 
even larger than expected based on the increase in luminal diameter, suggesting a 
hypertrophic outward remodeling. Figure 6F. Indeed, measurements of wall thickness 
confirmed a hypertrophic outward remodeling, which was not different between male and 
female C57Bl/6 mice. Figure 6G. There was no difference between male and female 
C57Bl/6 mice for luminal diameter, abluminal diameter, or wall thickness in the 
remodeled collateral.  
 
With no evidence of intersex differences in collateral midzone outward remodeling in 
C57Bl/6 mice, we examined if there was an impairment in collateral remodeling for 
BALB/c female mice. Like the C57Bl/6 mice, the lumen was larger for all ligated gracilis 
collaterals compared to the respective contralateral control, within both males and 
females, Figure 6E. The abluminal diameter was also greater for both male and female 
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mice, comparing the ligated gracilis collaterals to the contralateral control, Figure 6F.  
Both males and females exhibited larger wall thicknesses for the day-7 remodeled 
collaterals compared to the contralateral control, Figure 6G. There was no difference 
between male and female BALB/c mice for luminal diameter, abluminal diameter, or 
wall thickness in the remodeled or control collaterals. 
 
  
F 
E 
G 
D C 
B 
FIGURE 6 | Anterior gracilis collateral remodeling in C57Bl/6 and BALB/c mice following 
femoral artery ligation. (A) Representative day-7 post ligation collateral abluminal diameter 
alpha-VSMC stained (10x). (B) Representative day-7 post ligation collateral luminal-diameter 
polymer perfused (10x). (C) Representative alpha-SMA control anterior gracilis collateral (10x). 
(D) Representative control collateral luminal-diameter polymer perfused (10x). (E) Luminal 
diameter of the anterior gracilis collateral of day-7 post-ligation and control hindlimbs in BALB/c 
female (n=6,5) and male (n=6,6) mice, and C57Bl/6 female (n=4,5) and male (n=4,5) mice. (F) 
Abluminal diameter of the anterior gracilis collateral of day-7 post-ligation and control hindlimbs 
in BALB/c female (n=6,5) and male (n=6,6) mice, and C57BL/6 female (n=4,5) and male (n=4,5) 
mice. (G) Wall thickness of the anterior gracilis collateral of day-7 post-ligation and control 
hindlimbs in BALB/c female (n=6,5) and male (n=6,6) mice, and C57Bl/6 female (n=4,5) and 
male (n=4,5) mice. *P<0.05 male verses female control conditions.   
 
A 
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DISCUSSION  
 
Contemporary clinical evidence indicates a higher incidence of PAOD and associated 
likelihood of critical limb ischemia in women [10-15, 59]. Women are also less likely to 
survive, and exhibit worse prognosis following myocardial infarction [16, 17]. With these 
differences possibly due to discrepancies in vascular compensation, developing effective 
therapeutics necessitates understanding the mechanisms underlying these potential 
differences [20, 21]. Previous work is inconsistent on the impact of female sex on flow 
recovery following arterial occlusion, but suggested an impairment in collateral growth 
[21, 47, 50]. Therefore, we described the effect of arterial occlusion on collateral 
remodeling in healthy male and healthy reproductive-stage female mice.  
 
In functional ambulatory recovery evaluation, both male and female C57Bl/6 mice 
regained normal hindlimb function more quickly than BALB/c mice post-ligation, Figure 
4. The inter-strain findings are consistent with previous observations that BALB/c mice 
have greater hindlimb use impairment at days 3 and 7 when compared to C57Bl/6 models 
[52]. Furthermore, BALB/c mice had greater myofiber atrophy, greater myocyte 
apoptosis, and attenuated myogenic regulatory gene expression and stress-response 
signaling following hindlimb ischemia, with evidence in functional impairment [60]. No 
difference existed in days to normal ambulation between male and female mice with 
normal estrous cycles in either strain.  
 
In exploring the outward vascular remodeling mechanisms underlying the ambulatory 
recovery, it is known that the collateral stem outwardly remodels following an upstream 
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occlusion in male mice [57]. Although the collateral stem enlarges, the lack of VSMC 
proliferation in this area suggests the enlargement was due to other processes [58, 61-63]. 
Repositioning of VSMCs due to an altered mechanical environment is established, as 
physical alignment and reorientation of isolated cultured VSMCs in a position 
perpendicular to the stretch vector occurs due to cyclic stretch, and arteriolar inward 
remodeling in response to norepinephrine and angiotensin [64-66]. As such, we tested the 
hypothesis that enlargement in the collateral stem occurs via VSMC mechanoadaptation, 
and that female mice are deficient in this process. Although all smooth muscle cell 
lengths increased relative to their contralateral control, surprisingly, the only sex 
difference in remodeling was longer VSMCs in C57Bl/6 males compared to females. As 
the native VSMC lengths between C57Bl/6 mice were not different, these males may 
exhibit the ability to elongate VSMCs greater than females of the same strain, although 
this did not affect the diameter of the vessel in a measurable way. VSMC shape and 
migration are altered by many different stimuli, including humoral factors (ANGII, 
TGFb1, ET-1, etc.), neuronal contributors, intercellular VSMC paracrine factors, 
endothelial cell influences (NO, etc.), and mechanical forces such as active stress and 
strain [67]. Estrogen levels in men and postmenopausal women are lower than levels in 
non-pregnant women [41-43], and estrogen has been shown to cause an increase in 
norepinephrine levels [68]. Norepinephrine exposure has resulted in shortening of 
VSMCs [38]. Therefore, it is possible that if the females had higher baseline levels of 
norepinephrine, their VSMCs lengths may not lengthen as robustly, resulting in the 
sexual dimorphism seen. In examining an additional aspect of mechanoadaptation, all 
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VSMC overlaps decreased relative to their contralateral control, but there were no sex-
related remodeling differences among BALB/c or C57Bl/6 strains, Figure 5.  
 
As the anterior gracilis collateral exhibits smooth muscle cell proliferation, evidence of 
typical arteriogenesis [56, 58], we tested the hypothesis that female mice exhibit impaired 
arteriogenesis in this vessel. No differences were found between C57Bl/6 and BALB/c 
mice, consistent with prior day-7 collateral arteriole remodeling results, in which male 
BALB/c collateral outward remodeling was impaired at day-3 post arterial occlusion, but 
showed no difference at day-7 [56]. Vessel diameters and wall thickness were larger in 
the remodeled vessel than the control vessel in all sexes and strains. The only exception 
was the wall thickness of C57Bl/6 female mice. This measurement had a large amount of 
variability, which may be due to variations in the mice estrous cycles. 17-β-estradiol 
levels are variable during the cycle [69], and 17-β-estradiol increases the endothelial 
production of nitric oxide [46], which is an endothelial-derived vasodilator [70]. Nitric 
oxide diffuses into VSMCs, initiating a cascade that activates protein kinase G. This then 
regulates calcium concentrations and sensitization, and causes actin and myosin dynamic 
alterations that result in cellular relaxation, possibly altering wall thickness [71]. 
However, no difference existed between male and female C57Bl/6 mice for inner 
diameter, outer diameter, or wall thickness in the remodeled or control collaterals, Figure 
6. Therefore, this lack of difference in diameters may suggest the lack of increase in wall 
thickness to be artifact. As this finding suggests no obvious anatomical remodeling 
differences in the anterior gracilis collateral midzone of male and female mice, there may 
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be other factors accounting for any flow recovery differences previously observed, such 
as increased vascular resistance in the ischemic zone in females [50].  
 
Fewer preexisting collaterals in females with unimpaired remodeling, or dysregulated 
capillary arterialization and angiogenesis may explain increased vascular resistance in 
females, with collaterals remodeling to the same extent. However, no difference between 
male and female C57Bl/6 mice in number of α-smooth muscle actin-positive vessels was 
found at baseline in the midpoint of the semimembranosus muscle [50]. Despite this lack 
of difference, the small sample size of no more than 5 mice in each group leaves this 
possibility to be considered [50]. Furthermore, the collateral distribution between male 
and females may be different, so although there was no difference at the midpoint of the 
semimembranosus muscle, there may be fewer preexisting collaterals in other areas of the 
hindlimb. Despite no difference at day-7 post ligation in α-smooth muscle actin-positive 
vessels compared to baseline for females, there was an increase in males. This increase is 
suggestive of preexisting capillaries being transformed into collaterals, possibly due to 
pericyte recruitment, known as capillary arterialization [72, 73]. In a basic examination of 
angiogenesis, female C57Bl/6 mice had less fewer red blood cell-containing vessels in a 
Matrigel Plug Assay compared to males after 5 days, indicating dysregulation [50]. An 
increased ability in either of these mechanisms would explain lower vascular resistance in 
males. 
 
Alternatively, higher vascular resistance in female mice [46] may be due to impaired 
vasodilation in the ischemic zone, even without vessel growth impairment or difference 
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in baseline collateral density [50, 74]. Because reports concerning the impact of arterial 
occlusion on smooth muscle-dependent and endothelium-dependent vasodilation are 
inconsistent, it is unclear what component of the remodeling process may be affected. 
Vasodilation is impaired in response to endothelium-dependent agents in immature 
collaterals in animal models [75-79], but upon maturation is either restored [78] or 
continually impaired [79]. This may be explained by endothelial dysfunction induced by 
inflammatory conditions during remodeling [80], or an increase in collateral flow [81]. 
Hypercholesterolemia and ovariectomy in female mice each lead to impaired endothelial-
dependent vasodilation in resistance vessels [102], so it is possible that additional co-
morbidities or estrogen deficiency may precipitate sex-dependent causal effects on 
vasodilation impairment, possibly leading to higher female vascular resistance depending 
on female mice position in the estrous cycle [82].  
 
Impaired vasodilation may be partially contributed to smooth muscle cell dysfunction 
[83]. This dysfunction is suggested by diminished endothelium-dependent and 
independent dilation responses in immature feed arteries that are restored after maturation 
[83]. Although feed arteries and collaterals remodel differently, endothelium-independent 
vasodilation is also impaired in collateral vessels [79, 84, 85]. This impairment could be 
due to smooth muscle dysfunction caused by the smooth muscle cell phenotype change 
during proliferation in immature collaterals [86, 87]. Although there is conflicting 
evidence that vasodilation responses to sodium nitroprusside are intact at day-14 
following the induction of chronic ischemia [79], nitric oxide-induced, smooth muscle-
dependent dilation is impaired in intramuscular arterioles at 5-weeks post chronic 
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ischemia induction [79, 85]. Although the mechanism of the impairment is unknown in 
these reports, there is a possible relation to oxidative stress. This stress increases with 
chronic ischemia [88], impairing dilation response in the obese Zucker rat to sodium 
nitroprusside [89]. Impaired dilation may have increased vascular resistance in female 
C57Bl/6 mice, as they were less responsive to vasodilators at day-7 following femoral 
artery excision [50]. 
 
This research had several limitations regarding its interpretation. One of the potential 
limitations of this study is the non-standardization of the estrus cycle. This cycle in mice 
is approximately 4-5 days in length, consisting of the four phases: proestrus, estrus, 
metestrus and diestrus [90]. Through the duration of the study, the female mice were 
randomly cycling through these phases, undergoing several cycles. Although this non-
standardization is not optimal in determining correlative mechanisms, it more accurately 
reflects the healthy female general population hormonal cycle variation. Another 
limitation is the variation in ambulation scorers throughout the week. A different lab 
member is in charge of determining an ambulation score for the mice every day, which 
may have led to variation in the data due to the subjective nature of the measure. To 
mitigate this potential variation, it may be best to have one individual assign scores 
throughout the duration of the experiment, possibly limiting the data collection to days 1, 
3, and 6 post ligation to ease workload and still capture a comprehensive view of 
recovery. In addition, training videos or sessions could be created to minimize variation 
between scorers within the lab. Another possible limitation is the variation in time of day 
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in which the ambulation data was collected, so moving forward it would be 
recommended to score the mice at a similar time each day for consistency.  
 
In summary, the aim of these studies was to describe the effect of arterial occlusion on 
collateral remodeling in male and healthy reproductive stage female mice. The collateral 
stem enlarged seemingly due to mechanoadaptation in both BALB/c and C57Bl/6 mice. 
There were no major sex-related differences in the gracilis collateral stem or midzone 
remodeling or resultant functional ambulation, with the exception of longer VSMCs in 
male C57Bl/6 mice, at day-7 post femoral artery ligation in the collateral stem. As 
clinical evidence indicates a higher incidence of PAOD and associated likelihood of 
critical limb ischemia in women, as well as worse prognosis and decreased survival post 
myocardial infarction, understanding the possible differences in underlying vascular 
compensation mechanisms is crucial [10-17, 59]. As these differences were not captured 
in our specific investigation of arteriogenesis, an evaluation of microvascular remodeling 
in the ischemic zone and collateral vasodilation would be of interest. Furthermore, as 
oophorectomy reduces flow-mediated outward remodeling and decreased vessel densities 
in mice [46], arteriogenesis should be evaluated in the hindlimb following oophorectomy 
with estrogen depletion. 17-β-estradiol increases the endothelial production of nitric 
oxide, and flow-mediated outward remodeling following oophorectomy is rescued by 17-
β-estradiol, with increased age a risk factor for PAOD development [11, 42, 46]. The 
determination of any underlying mechanistic sex-specific differences could be the 
foundation in which targeted therapeutics are developed, crucial for closing the prognosis 
gap between men and women in the global treatment of PAOD.  
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APPENDICES 
Appendix A: Raw Images  
Wideview Microscopy (10x) 
C57Bl/6 Females: 
 
N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil (Did not use)  
A                B 
A              B 
A              B 
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N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=3 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
A              B 
 A             B 
A               B 
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N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil  
 
N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
A            B 
A             B 
A            B 
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N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
C57Bl/6 Males: 
 
N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
A            B 
A             B 
A             B 
  36 
 
N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
A            B 
A            B 
A              B 
  37 
 
N=3 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil  
 
N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil (Did not use) 
A            B 
A            B 
A          B 
A           B 
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N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=6 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=6 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
 
 
 
 
 
 
 
 
 
 
 
 
A      B 
A              B 
A     B 
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BALB/C Females: 
 
N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil  
A             B 
A     B 
A            B 
A     B 
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N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil  
 
N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
A     B 
A       B 
A     B 
A     B 
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N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=6 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=6 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil  
 
 
 
 
 
 
 
 
 
 
 
 
A     B 
A       B 
A              B 
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BALB/C Males: 
 
N=1 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=1 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=2 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
A        B 
A             B 
A       B 
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N=2 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=3 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=3 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
A         B 
A             B 
A                   B 
A       B 
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N=4 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil  
 
N=4 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=5 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
A               B 
A                   B 
A                   B 
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N=5 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
N=6 Anterior Gracilis Collateral Day-7 Post-Femoral Artery Ligation A) Alpha-Smooth 
Muscle Actin B) Microfil   
 
N=6 Anterior Gracilis Collateral Control A) Alpha-Smooth Muscle Actin B) Microfil   
 
 
 
 
 
 
 
 
 
A                B 
A               B 
A               B 
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Confocal Images (40x) 
C57Bl/6 Females: 
 
N=1 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
A                   B 
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N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
  
N=3 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
A                          B 
A             B 
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N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
A                        B 
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N=5 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
A                  B 
A              B 
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N=7 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
  
N=8 Profunda Femoris Artery Day-7 Post-Ligation 
 
 
 
 
 
 
 
A      B 
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C57Bl/6 Males: 
  
N=1 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
A     B 
A                  B 
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N=3 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
A                       B 
A             B 
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N=5 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
  
N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
A                             B 
A                        B 
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N=7 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A       B 
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BALB/C Females: 
 
N=1 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
A        B 
A                  B 
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N=3 A) Profunda Femoris Artery Day-7 Post-Ligation (Did not use) B) Profunda 
Femoris Artery Control  
 
N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
A       B 
A                         B 
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N=5 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control (Did not use) 
 
 
 
 
A           B 
A                                         B 
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BALB/C Males: 
 
N=1Profunda Femoris Artery Day-7 Post-Ligation  
  
N=2 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
A                                 B 
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N=3 Profunda Femoris Artery Control 
 
N=4 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control  
A                    B 
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N=5 Profunda Femoris Artery Control 
 
N=6 A) Profunda Femoris Artery Day-7 Post-Ligation B) Profunda Femoris Artery 
Control 
 
 
 
 
 
 
A                          B   
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Appendix B: Tables 
Table I. Days to Normal Ambulation Post-Femoral Artery Ligation in C57Bl/6 and BALB/c 
Mice  
 Sex n Days to Normal Ambulation ± SE 
C57Bl/6 
Males 13 3.9 ± 0.4 
Females 13 3.9 ± 0.4 
BALB/c 
Males 6 5.8 ± 0.2 
Females 6 6.0 ± 0.0 
 
 
Table II. Daily Ambulation Scoring in C57Bl/6 and BALB/c Mice  
 
Sex n 
Day 1 Post-
Ligation ± 
SE 
Day 2 Post-
Ligation ± SE Day 3 Post-Ligation ± SE Day 4 Post-Ligation ± SE Day 5 Post-Ligation ± SE Day 6 Post-Ligation ± SE 
C57Bl/6 
Males 13 1.6 ± 0.2 0.8 ± 0.1 0.5 ± 0.2 0.4 ± 0.2 0.3 ± 0.1 0.0 ± 0.0  
Females 13 1.4 ±0.2 1.0 ± 0 0.1 ± 0.1 0.1 ± 0.1 0.0 ± 0.0   0.3 ± 0.2 
BALB/c 
Males 6 3.0 ± 0 2.0 ±	0.0 2.4 ± 0.2 1.8 ± 0.3 1.7 ± 0.3 1.0 ± 0.3  
Females 6 2.8 ± 0.2 1.8 ± 0.4 2.3 ± 0.2 1.7 ± 0.2 1.3 ± 0.2 1.7 ± 0.2  
 
 
Table III. Indicators of Mechanoadaptation in C57Bl/6 and BALB/c Mice  
 
Sex Limb n 
VSMC Length (µm) ± SE Overlap (µm) ± SE 
C57Bl/6 
Males 
Day-7 
Post-Ligation 6 329 ± 19 19 ± 2 
Control 7 273 ± 15 27 ± 2 
Females 
Day-7 
Post-Ligation 8 288 ± 13 16 ± 1 
Control 7 235 ± 19 26 ± 2 
BALB/c 
Males 
Day-7 
Post-Ligation 4 325 ± 9 24 ± 2 
Control 5 280 ± 10 29 ± 1 
Females 
Day-7 
Post-Ligation 4 327 ± 10 22 ± 2 
Control 5 297 ± 11 35 ± 2 
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Table IV. Anterior Gracilis Collateral Remodeling in C57Bl/6 and BALB/c Mice.  
 
Sex Limb n 
Outer Diameter 
(µm) ± SE Inner Diameter (µm)  ± SE Wall Thickness (µm) ± SE 
C57Bl/6 
Males 
Day-7 
Post-Ligation 4 93 ± 9 70 ± 7 12 ± 1 
Control 5 50 ± 5 38 ± 4 6 ± 1 
Females 
Day-7 
Post-Ligation 4 95 ± 12 62 ± 7 17 ± 6 
Control 5 46 ± 5 29 ± 3 8 ± 1 
BALB/c 
Males 
Day-7 
Post-Ligation 6 103 ± 9 67 ± 7 18 ± 2 
Control 6 50 ± 7 37 ± 4 7 ± 3 
Females 
Day-7 
Post-Ligation 6 100 ± 7 70 ± 6 17 ± 1 
Control 5 46 ± 3 35 ± 3 6 ± 1 
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Appendix C: Femoral Artery Ligation Protocol  
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Appendix D: Perfusion Fixation Protocol
 
 
Date ______________ Perfusion Fixation Initials____________ 
 
Mouse Information 
DOB: ___________________ 
Sex: ____________________  
Tag: ____________________ 
Genotype/strain: __________ 
Cage: ___________________ 
Weight(g): _________________ 
 
Materials 
Non-Sterilize Dissection Instruments 
____1. Forceps (1) 
____2. Fine forceps (2) 
____3. Bone scissors (1) 
____4. Curved Iris scissors (1) 
____5. Microdissection scissors (1) 
____6. Vascular clamp (1) 
____7. Castroviejos  
 
Obtained in surgery suite 
____8. Tape 
____9. 20 mL syringes (2) 
____10. 5 mL syringe (1) 
____11. Syringe pump 
____12. Petri-dish 
____13. Bench cover 
____14. Depilatory cream 
____15. Clippers 
____16. Veterinary ointment  
____17. Heating pad 
____18. Catheter 
____19. Non-sterile saline 
____20. Cotton swabs 
____21. Gauze sponges  
____22. Saran wrap 
 
Vasodilator Cocktail Preparation 
____23. Turn on water bath to 37ºC 
____24. 400 µL heparin  
____25. 1mL SNP(orange) 
____26. 600µL Adenosine(clear) 
____27. 38mL PBS solution 
____28. 5 mL 4% Paraformaldehyde (PFA) 
____29. Thaw SNP, Adenosine and PFA 
____30. Add heparin, SNP, Adenosine, and PBS 
solution together in a 50mL conical 
____31. Place vasodilator cocktail in water bath 
 
Procedure Preparation 
____32. Obtain saline filled petri-dish, cotton 
swab, and instruments  
 
Fixation 
____33. Remove hair on both legs by shaving & 
depilation  
____34. Tape animal in supine position to 4X4 
gauze sponge over heating pad 
____35. Expose muscles of interest and blunt 
dissect to aid in removal post-fixation, 
then cover with saran wrap 
____36. Fill 20mL syringe with 20 mL warm 
Vaso D, load into syringe pump and 
attach catheter 
____37. Flow liquid through the catheter to the 
tip to prevent air from being injected 
into circulatory system 
____38. Lift skin from muscle in abdominal 
region and cut a window over the 
sternum 
____39. Lift sternum and cut connective tissue 
under 
____40. Use bone scissors in hole to quickly cut 
through the ribs to the armpit on both 
sides  
____41. Clamp sternum with castroviejos and 
reflect towards mouse’s head 
____42. Cut diaphragm with curved iris scissors 
to open chest cavity  
____43. Cut away excess tissue around the heart 
____44. Make a small incision in the apex of the 
heart 
____45. Insert catheter and clamp with vascular 
clamp and cut right atrium 
____46. Inject Vaso D solution into animal 
approximately 20mL X 2  (5mL/min), 
soaking up excess blood and fluids with 
gauze sponges  
____47. Inject 5 mL PFA (4 mL/min) 
____48. Dissect out muscles of interest using fine 
forceps and microdissection scissors  
____49. Turn off water bath, cover scope, turn 
off oxygen, turn off isofluorane, and 
clean instruments 
 
Notes 
__________________________________________ 
__________________________________________ 
__________________________________________ 
__________________________________________ 
__________________________________________ 
__________________________________________ 
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Appendix E: Microfil Protocol  
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Appendix F: ASMA Staining Protocol  
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Appendix G: Confocal Protocol     
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Appendix H: Inadequate Methods   
There were several methods that did provide an adequate assessment of the data. These 
methods are outlined below, along with suggestions for possible mitigation of challenges.  
 
Transilluminator 
 
To attempt to visualize the red blood cell column to measure inner diameter in the 
gracilis collateral midzone, a transilluminator was used. A transilluminator is a water-
resistant probe with a light at the distal end designed to fit behind the dissected anterior 
gracilis in vivo. The light was placed directly behind the collateral midzone, and images 
were captured utilizing an Olympic BXFM intravital microscope. However, the method 
did not provide images with clearly discernable red blood cell columns, so inner diameter 
measurements were not successfully recorded. Possible reasons for failure are depth of 
vessels resulting in challenging focusing for microscope, or incorrect microscope 
settings. Suggestions for possible mitigation include adjustment of light settings or 
location of probe to result in clearer images, adjustment of imaging variables to result in 
clearer images, removal of tissue overlying gracilis muscle, and adjustment of post-
processing of images. A sample image is seen below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Endothelial Lectin Stain 
 
To attempt to visualize endothelial cells to measure inner diameter in the gracilis 
collateral midzone, a lectin stain was used. Lectin specifically binds to glycoproteins 
located in the basal membrane of endothelial cells [91], and can be visualized using 
widefield fluorescent microscopy. This protocol can be seen in Appendix I. In addition to 
the recommended incubation time and concentration in the protocol, I also performed 
1:40 4 hour, 1:20 2 hour, 1:20 4 hour, and 1:20 overnight incubation. However, upon 
imaging there was only nonspecific activation of cells, not allowing clear visualization of 
the endothelium. As lectin depends on diffusion through tissue, it is possible that the 
gracilis collateral is too deep in the anterior gracilis muscle for the molecule to bind to the 
endothelium. Suggestions for possible mitigation include adjustment of antibody 
In vivo gracilis collateral midzone visualization 
utilizing transilluminator.  
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concentrations, incubation times, and permeabilizing agents to allow for binding to the 
collateral endothelium, adjustment of widefield fluorescent filters, and adjustment of 
post-processing of images. A sample image of a lectin stained image overlaid to an alpha-
smooth muscle actin image is seen below, with no clear visualization of the endothelium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evans Blue Dye 
 
To visualize inner diameter of the gracilis collateral midzone, Evans Blue Dye was 
utilized. Evan’s blue dye binds to serum albumin, resulting in luminal staining of vessels, 
allowing visualization upon microscopy [92]. It is injected into the ventral artery in the 
tail. However, upon intravital microscopy using a transilluminator, clear visualization of 
the inner diameter was not obtained. This may be due to diffusion of the dye to other 
tissues, as the myofibers also turned blue, as well as challenges previously discussed with 
transillumination. Potential mitigation includes adjustment of transillumination 
technique, concentration of dye or volume injected, a different method of injection such 
as intracardiac following perfusion fixation, adjustment of widefield microscopy bright-
light settings, or adjustment of post-processing of images.  
 
Estrous Cycle Determination 
 
To assign where a female mouse was in the murine estrous 
cycle on day-7 post ligation, vaginal visualization was 
utilized, as outlined in a prior study [93]. Images were 
captured using a hand-held digital camera of the vaginal 
area, and then compared to the reference images in the 
publication. However, as there were no personnel in the lab 
trained in this subjective method, there was no way to 
confirm the correct assignment of the estrous cycle. To 
mitigate this moving forward, collaboration with the group 
who created this method would be ideal to ensure proper 
training and success in assignment. 
 
Lectin stain. (A) Lectin positive image of 1:20 dilution incubated for 4 hours. (B) Lectin 
positive image (green) overlaid with alpha-smooth muscle actin positive (red). 
A                                                           B 
Example image for vaginal 
visualization. 
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Length Density and Volume Fraction 
 
To determine vessel density in the anterior gracilis muscle along the stem, midzone and 
reentry portions, length density and volume fraction calculations were utilized following 
alpha-smooth muscle actin staining as described in Appendix I, and imaged using 
widefield microscopy. Images were taken at the stem, midzone, and reentry regions of the 
vessel and imported into Rapid Analysis of Vessel Elements (RAVE) software. Length 
density is a measure of total arteriole length per unit area of tissue, and volume fraction 
represents the total length of all vessels divided by total pixel area, with the method 
outlined in a prior publication [94].  However, because images were not in focus all the 
way through the depth of collateral location in the muscle, it was difficult to use the 
software to assign a correct binary to distinguish between vascular and muscular tissue. 
As the images were taken on the widefield microscope, utilization of the confocal 
microscope and creation of a z-stack would be ideal for the uniform focus of the vessels 
necessary for RAVE software utilization. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Vessel Density Measurement. (A) Rapid Analysis of Vessel Elements (RAVE) 
Software GUI. (B,C) Representative alpha-smooth muscle actin positive images 
that were uploaded for assessment.   
B                                                     C 
A 
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Appendix I: Lectin Stain Protocol   
 
